Evidence map›Paper›PMID 20971736›Full record

ArticleThe American journal of pathology2010

Development of a bioengineered skin-humanized mouse model for psoriasis: dissecting epidermal-lymphocyte interacting pathways.

Sara Guerrero-Aspizua, Marta García, Rodolfo Murillas, Luisa Retamosa, Nuria Illera, Blanca Duarte, Almudena Holguín, Susana Puig, Maria Isabel Hernández, Alvaro Meana and 4 more

Abstract readEvaluation Study
In one paragraph

Article in The American journal of pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Effect of Systemic Administration of CD4Comparative medicine · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Mouse Models of Alopecia Areata: C3H/HeJ Mice Versus the Humanized AA Mouse Model.The journal of investigative dermatology. Symposium proceedings · 2020
    Review
  10. Article
  11. Article
  12. Bioprinting for Skin.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  13. Article
  14. Bioengineered Skin Intended for Skin Disease Modeling.International journal of molecular sciences · 2019
    Review
  15. Review
  16. Contribution ofMediators of inflammation · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sara Guerrero-AspizuaRegenerative Medicine Unit, Epithelial Biomedicine Division, Basic Research Department, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Av. Complutense 22, Edificio 70A, 28040 Madrid, Spain.
Marta García
Rodolfo Murillas
Luisa Retamosa
Nuria Illera
Blanca Duarte
Almudena Holguín
Susana Puig
Maria Isabel Hernández
Alvaro Meana
Jose Luis Jorcano
Fernando Larcher
Marta Carretero
Marcela Del Río

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past few years, whole skin xenotransplantation models that mimic different aspects of psoriasis have become available. However, these models are strongly constrained by the lack of skin donor availability and homogeneity. We present in this study a bioengineering-based skin-humanized mouse model for psoriasis, either in an autologous version using samples derived from psoriatic patients or, more importantly, in an allogeneic context, starting from skin biopsies and blood samples from unrelated healthy donors. After engraftment, the regenerated human skin presents the typical architecture of normal human skin but, in both cases, immunological reconstitution through intradermal injection in the regenerated skin using in vitro-differentiated T1 subpopulations as well as recombinant IL-17 and IL-22 Th17 cytokines, together with removal of the stratum corneum barrier by a mild abrasive treatment, leads to the rapid conversion of the skin into a bona fide psoriatic phenotype. Major hallmarks of psoriasis were confirmed by the evaluation of specific epidermal differentiation and proliferation markers as well as the mesenchymal milieu, including angiogenesis and infiltrate. Our bioengineered skin-based system represents a robust platform to reliably assess the molecular and cellular mechanisms underlying the complex interdependence between epidermal cells and the immune system. The system may also prove suitable to assess preclinical studies that test the efficacy of novel therapeutic treatments and to predict individual patient response to therapy.

Indexed as

3T3 CellsAlgorithmsAnimalsBioengineeringCell CommunicationCells, CulturedDisease Models, AnimalEpidermisHumansLymphocytesMiceMice, NudeMice, SCIDModels, BiologicalPsoriasisSignal Transduction

Identifiers

PMID20971736
PMCPMC2993308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.